IVF — INVO Fertility Cashflow Statement
0.000.00%
- $2.91m
- $4.54m
- $6.53m
- 16
- 73
- 14
- 24
Annual cashflow statement for INVO Fertility, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.35 | -6.65 | -10.9 | -8.03 | -9.1 |
| Depreciation | |||||
| Non-Cash Items | 4.41 | 4.2 | 2.96 | 2.61 | 3.34 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.846 | -3.61 | 1.25 | 0.472 | 1.86 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -4.78 | -6.03 | -6.6 | -4.76 | -2.97 |
| Capital Expenditures | -0.089 | -0.455 | -0.013 | -0.445 | -0.184 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.098 | -1.7 | -0.068 | -2.05 | 0.548 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.187 | -2.15 | -0.081 | -2.49 | 0.364 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13.8 | 3.77 | 1.09 | 7.39 | 3.12 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.86 | -4.41 | -5.59 | 0.142 | 0.509 |